CAR 70-BCMA CAR-T cell therapy (The General Hospital Of Western Theater Command)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameCAR 70-BCMA CAR-T cell therapy (The General Hospital Of Western Theater Command)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacementsCD70 antigen modulatorsB-cell maturation protein modulators
TargetsCD70 antigenB-cell maturation protein
Therapy Area/IndicationsNeoplasms, Plasma Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe General Hospital Of Western Theater Command
China Registration ClassN/A

Develop Information

Active CompaniesThe General Hospital Of Western Theater Command
Inactive CompaniesN/A
Active IndicationsNeoplasms, Plasma Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A